Lowell Blake & Associates Inc. Amgen Inc Transaction History

Lowell Blake & Associates Inc.

  • $1.4 Billion
  • Q3 2023

A detailed history of Lowell Blake & Associates Inc. transactions in Amgen Inc stock. As of the latest transaction made, Lowell Blake & Associates Inc. holds 1,285 shares of AMGN stock, worth $339,869. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,285
Previous 1,285 -0.0%
Holding current value
$339,869
Previous $285,000 21.05%
% of portfolio
0.02%
Previous 0.08%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$214.27 - $253.37 $214 - $253
-1 Reduced 0.08%
1,285 $285,000
Q1 2023

May 12, 2023
SELL
$225.79 - $275.2 $27,997 - $34,124
-124 Reduced 8.79%
1,286 $310,000
Q4 2022

Feb 10, 2023
BUY
$229.03 - $291.01 $49,012 - $62,276
214 Added 17.89%
1,410 $370,000
Q3 2022

Nov 14, 2022
BUY
$224.46 - $253.15 $58,359 - $65,819
260 Added 27.78%
1,196 $270,000
Q2 2022

Aug 11, 2022
SELL
$230.71 - $256.74 $20,763 - $23,106
-90 Reduced 8.77%
936 $228,000
Q4 2021

Feb 11, 2022
SELL
$198.88 - $227.6 $31,820 - $36,416
-160 Reduced 13.49%
1,026 $231,000
Q2 2021

Jul 29, 2021
BUY
$233.58 - $259.14 $277,025 - $307,340
1,186 New
1,186 $289,000
Q4 2020

Feb 04, 2021
SELL
$216.38 - $257.67 $243,211 - $289,621
-1,124 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$197.81 - $242.74 $113,740 - $139,575
-575 Reduced 33.84%
1,124 $265,000
Q4 2019

Jul 01, 2020
BUY
$189.21 - $243.2 $321,467 - $413,196
1,699 New
1,699 $410,000

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Lowell Blake & Associates Inc. Portfolio

Follow Lowell Blake & Associates Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowell Blake & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lowell Blake & Associates Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email